⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PRO.MED.CS Praha a.s. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
PRO.MED.CS Praha a.s.
↗Prague, Czech Republic
PRO.MED.CS Praha a.s. is an independent, fully integrated Czech pharmaceutical company headquartered in Prague. The company specializes in the development, research, and manufacturing of solid medicinal forms, including tablets, film-coated tablets, and capsules, with an annual production volume exceeding one billion units.
The company maintains its own scientific-research base and focuses on providing affordable, high-quality medicines. Its therapeutic portfolio is primarily concentrated on gastrointestinal, cardiovascular, and central nervous system (CNS) diseases, with products exported to more than 30 countries across Central and Eastern Europe, Central Asia, and increasingly, Western Europe.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic and Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:1989
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Operates through a network of partner companies and own representative offices for distribution.
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Roman Hosek - ICT Director / CIO
LINKS
Website:promedcs.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PRO.MED.CS Praha a.s.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.